<unk>  should not be taken by people with obstructive sleep apnea, myasthenia gravis, severe liver disease, respiratory depression; or by children, or people with psychotic illnesses. It should not be taken by people who are or have been addicted to other substances. Use of<unk>  may impair driving skills with a resultant increased risk of road traffic accidents. This adverse effect is not unique to<unk> , but also occurs with other hypnotic drugs. Caution should be exercised by motor vehicle drivers. In 2013, the FDA recommended the dose for women be reduced and that prescribers should consider lower doses for men due to impaired function the day after taking the drug.<unk>  should not be prescribed to older people, who are more sensitive to the effects of hypnotics including<unk>  and are at an increased risk of falls and adverse cognitive effects, such as delirium and neurocognitive disorder.<unk>  has not been assigned to a pregnancy category by the FDA. Animal studies have revealed evidence of incomplete ossification and increased intrauterine fetal death at doses greater than seven times the maximum recommended human dose or higher; however, teratogenicity was not observed at any dose level. There are no controlled data in human pregnancy. In one case report,<unk>  was found in cord blood at delivery.<unk>  is recommended for use during pregnancy only when benefits outweigh risks.
Zolpidem
Medazepam
Halazepam
Cinolazepam
Oxazepam
Nimetazepam
Dimethazan
Premazepam